As the world’s only transcranial-intranasal brain photobiomodulation (PBM) device, the Vielight Neuro Gamma is is the result of years of engineering and research.
The beneficial cognitive effects of the Vielight Neuro Gamma are featured in the most brain photobiomodulation research publications in the world, spanning from neurodegeneration to cognitive improvement.
Clinical research with our technology has produced improvements in cognition, memory and blood flow.
Gamma (40Hz): focus, memory, brain energy
Vielight technology quality is guaranteed by medical grade certification.
Introducing the Vielight Neuro Gamma: Your Next-Generation Brain Stimulation Device
Enhance your cognitive performance with the Vielight Neuro Gamma, a powerful and extensively researched brain photobiomodulation (PBM) device, equipped with intranasal technology. This cutting-edge device is engineered to be effective, safe, and remarkably user-friendly. It harnesses patented transcranial-intranasal technology, offering a distinctive and compelling approach to stimulating the Default Mode Network in the brain.
The Neuro Gamma transmits pulsed near-infrared (NIR) energy through the cranium, initiating the process of brain stimulation known as photobiomodulation. Through our advanced engineering, we've achieved a remarkable capability - extracting one of the highest levels of power from a near-infrared LED energy source, all without generating heat.
Operating at a frequency of 40 Hz, the Neuro Gamma aligns with neural gamma brain oscillations. Gamma brain waves are associated with increased focus, enhanced information processing, memory improvement, and elevated brain energy levels.
It's important to note that our Neuro Gamma technology has been a key component in independent research on brain photobiomodulation, contributing significantly to the global understanding of this field.
Choose the Vielight Neuro Gamma to experience next-generation brain stimulation that has the potential to boost your focus, cognitive performance, and memory, based on rigorous research and innovative technology.
Why the nose?
Being just 3 inches from the brain, the intranasal channel is the most efficient channel for photobiomodulation of the ventral (underside) brain area. These ventral structures within the brain’s core have important functions.
Engineering behind the Vielight Neuro
The Vielight Neuro enables direct contact with the scalp’s surface to maximize energy transmission and penetration while microchip-boosted cold LED diodes generate substantial power without releasing heat. Additionally, our patented intranasal technology enables photobiomodulation of the ventral brain areas.
Vielight Neuro – NIR light energy penetration through a human cadaver.
Biological effects of the Vielight Neuro
Default-mode network activity in
the PBM group—(A) baseline and (B) week
12 and in the usual care group—(C) baseline and (D) week 12. The posterior cingulate cortex (1, -61, and 38) was used as
seed in the analysis
Comparing EEG Power Spectrum:
Non-parametric cluster-based permutation test comparing the rest EEG power spectrum between active and sham tPBM. Topographical maps are color-coded according to the permutation tests t-values. Clusters of electrodes with significant difference between the two conditions are marked in ‘+’ sign (p < 0.05 and αcluster = 0.01). (a) Difference between post and pre active tPBM. (b) Difference between post and pre sham tPBM. (c) Difference between pre active and sham tPMB. (d) Difference between post active and sham tPMB.
tPBM's Impact on Resting-State EEG:
Active vs Sham Stimulation Compared by Frequency Bands.
Influence of tPBM on resting-state electroencephalography. Box plot illustrates the median and range of power spectrum across all electrodes for each oscillatory frequency bands. (a) Effect of active tPBM on power spectrum pre (green line) and post (red line). (b) Effect of sham tPBM on power spectrum pre (green line) and post (red line). (c) Difference between Active and Sham tPBM: Change of power spectrum Post-Pre for active (red line) and sham (green line) tPBM. Active versus sham stimulation revealed significant lower alteration in delta and theta power and higher change in alpha, beta and gamma frequency bands.
Manufacturer |
Vielight Inc |
---|---|
LED Power |
1000 mW per module |
Power Density | Irradiance |
100 mW/cm² (3) : Rear Transcranial LEDs |
Est. Area of Irradiance |
400cm² (+/- 50cm²) including Intranasal module footprint |
Targeted Brain Network |
Default Mode Network |
Head Size Suitability |
Minimum age: 5 years old based on published study data |
Medical Grade Certification |
ISO13485 and MDSAP |
Safety Certification |
TÜV Rheinland |
Warranty |
24 months |
Satisfaction Guarantee |
We have an 80% refund policy, valid for 3 months from the time of purchase |
What wavelength does the Vielight Neuro emit?
The Vielight Neuro emits pulsed 810nm NIR energy to enable brain stimulation through the photobiomodulation process.
Why the 810nm wavelength?
The 810nm wavelength has the deepest penetration through tissue and bone, enabling photonic transmission to neuronal mitochondria.
What is the difference between the Duo, Gamma and Alpha models?
The Gamma model pulses NIR light energy at 40 Hz, which has a neuromodulating effect on Gamma neural oscillations. Theoretical brain stimulation effects are an increase of memory activity, perception, cognition.
The Alpha model pulses NIR light energy at 10 Hz. This frequency is similar to neural alpha waves. Theoretical brain stimulation effects on alpha waves have a correlation with the brain’s resting state, offering support for mental coordination, mindfulness and learning.
The Duo makes both of these pulse rates available to you – having both pulse rates brings the most benefits.
How much power do your brain photobiomodulation devices generate?
Our brain photobiomodulation devices generate sufficient power to penetrate the skull and produce statistically significant results in independent research studies.
What is the recommended usage?
The general recommended usage is to use once every other day before experimenting with more frequent usage, not exceeding once per day. For more serious cognitive impairment, the recommendation is once per day, six days a week. Please note these recommendations are theoretical, anecdotal by nature and only based on published data or ongoing clinical trials with yet unpublished results.
Condition | Topic | Institution | Vielight Device | Research Type | Status |
---|---|---|---|---|
|
University of California San Francisco | US Veterans Affairs | Vielight Neuro Gamma | Clinical Study | Completed |
|
Harvard Medical School | Boston University School of Medicine | Vielight Neuro Gamma | Clinical Study | Completed |
|
Unity Health, Toronto | Vielight Neuro Gamma | Clinical Study | Analysis Stage |
|
University of Florida | University of Arizona | National Institute on Aging | Vielight 810 [MIP] | Phase 2 Clinical Trial (n=168) | Ongoing |
|
St Michael’s Hospital | Vielight Inc | Vielight Neuro Gamma | Phase 3 Clinical Trial (n=228) |
Ongoing |
|
University of California San Francisco | US Veterans Affairs | Vielight Neuro Gamma | Clinical Study | Results Analysis |
|
Department of Neurology, University of Utah | Vielight Neuro Gamma | Clinical Trial (n=49) | Pre-publication |
|
Boston University School of Medicine | Harvard Medical School | Vielight Neuro Gamma | Clinical Study | Completed |
|
VA Advanced Imaging Research Center, San Francisco VA Health Care System | Vielight Neuro Gamma | Clinical Study | Completed |
|
Boston Veterans Affairs Research Institute | Vielight Neuro Gamma | Clinical Study | Ongoing |
|
University of Sydney | Vielight Neuro Gamma | Clinical Study | Completed |
|
University of Florida | Vielight 810 [MIP] | Phase 2 Clinical trial (n=135) | Ongoing |
|
University of Sydney | University of Brisbane | Vielight Neuro Gamma | Clinical Study | Registered |
|
University of California San Francisco | US Veterans Affairs | Vielight Neuro Alpha | Clinical Study | Completed |
|
Neurodevelopment Division, Istituto di Neuroscienze, Italy | Vielight Neuro Duo | Clinical Study | Completed |
|
Vielight Inc | Vielight RX Plus | Pivotal Phase 3 Clinical Trial (n=295) | Completed |
|
University of Toronto | Vielight Inc | Vielight Neuro Gamma | Clinical Study | Completed |
|
Vielight Inc | Vielight Neuro Alpha | Clinical Study | Pre- Publication |
|
Princeton University | University of Alberta | Vielight Inc | Vielight Neuro Alpha | Research Study | Completed |
|
Vielight Inc | Vielight RX Plus | Pivotal Phase 3 Clinical Trial (n=295) | Completed |
|
Harvard Medical School | Vielight Blue [MIP] | Scientific Study | Completed |
|
Harvard Medical School | Vielight Blue [MIP] | Scientific Study | Completed |
|
Harvard Medical School | Vielight Blue [MIP] | Scientific Study | Completed |
|
University of Deusto, Spain | University of Montpellier, France | Pennsylvania State University | Vielight Neuro Gamma | Clinical Research (n=56) | Completed |
|
University of Alberta | Polytechnic University of Turin | Vielight Neuro Alpha | Scientific Study | Completed |
Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial
Institutes – University of California San Francisco & the Veterans Affairs USA
[ Published Study Device: Vielight Neuro Gamma ]
Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report
Co-authoring institutes – Harvard Medical School, Boston University School of Medicine
[ Published Study | Device: Vielight Neuro Gamma ]
Vielight Neuro RX Gamma – Alzheimer’s Disease Pivotal Phase III Clinical Trial (n=228)
Co-institutes – St Michael’s Hospital, Toronto
[ Clinical Trial Information Link ] (228 participants | 3 years | Ongoing)
Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI) / Dementia
Co-institutes – Unity Health Toronto, Toronto
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ]
Revitalizing Cognition in Older Adults at Risk for Alzheimer’s Disease With Near-Infrared Photobiomodulation
Institutes – University of Florida, University of Arizona, National Institute on Aging (NIA)
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (168 participants | 5 years | Registration)
Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer’s Disease
Institutes – University of California San Francisco UCSF
[ Clinical Trial Information Link / Device: Vielight Neuro Gamma ] (16 participants | 1.5 years | Ongoing)
Transcranial Photobiomodulation Treatment Effects In Former Athletes With Repetitive Head Hits (n=49)
Institutes – Department of Neurology, University of Utah
[ Published Abstract Link | Device: Vielight Neuro Gamma ] (49 participants | Pending publication)
Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy
Institutes – Boston University School of Medicine, Harvard Medical School
[ Published Study Link | Device: Vielight Neuro Gamma ]
Changes in Brain Function and Structure After Self-Administered Home Photobiomodulation Treatment in a Concussion Case
Institutes – VA Advanced Imaging Research Center, San Francisco VA Health Care System, Departments of Radiology & Biomedical Imaging and Psychiatry & Behavioral Sciences, University of California, San Francisco
[ Published Study Link | Device: Vielight Neuro Gamma ]
Photobiomodulation to Improve Cognition in TBI, With fMRI
Institutes – Boston Veterans Affairs Research Institute
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (20 participants | 1 years | Ongoing)
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: A prospective proof-of-concept study
Institutes – University of Sydney, University of New South Wales, Griffith University
[ Published Study Link Device: Vielight Neuro Gamma ]
Pilot Intervention With Near Infrared Stimulation
Institutes – University of Florida
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (135 participants | 4 years | Ongoing)
Evaluation of dose of Photobiomodulation (Light) Therapy and Physiotherapy for Improving Quality of Life Outcomes and Mobility in Parkinson’s Disease (Pilot)
Institutes – University of Sydney, University of Brisbane
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (16 participants | 1.5 years | Ongoing)
Improvements in Gulf War Illness Symptoms After Near-Infrared Transcranial and Intranasal Photobiomodulation: Two Case Reports
Institutes – University of California San Francisco & the Veterans Affairs USA
[ Published Study Link | Device: Vielight Neuro Alpha ]
Transcranial Photobiomodulation for the Treatment of Children with Autism Spectrum Disorder (ASD): A Retrospective Study
Institutes – Neurodevelopment Division, Istituto di Neuroscienze, Italy, Department of Psychiatry, Albert Einstein College of Medicine, NY
[ Published Study Link Device: Vielight Neuro Duo ]
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
Various clinical sites
[ Pre-print of Results ] (295 participants | 1 year | Pre-publication)
A Pilot Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
Various clinical sites
[ Clinical Trial Information ] (36 participants | 1 year | Recruitment)
Enhancement of Divergent Creative Thinking After Transcranial Near-Infrared Photobiomodulation Over the Default Mode Network
Institutes – University of Deusto | University of Montpellier | Pennsylvania State University
[ Published Study Link Device: Vielight Neuro Gamma ]
Pulsed Near Infrared Transcranial and Intranasal Photobiomodulation Significantly Modulates Neural Oscillations: a pilot exploratory study
Institutes – Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
[ Published Study Link (Nature, Scientific Reports, 2019) | Device: Vielight Neuro Gamma ]
Modulation of cortical oscillations using 10hz near-infrared transcranial and intranasal photobiomodulation: a randomized sham-controlled crossover study
[ Abstract Text Link | Device: Vielight Neuro Alpha ]
Near-Infrared Photobiomodulation of Living Cells, Tubulin, and Microtubules In Vitro
Institutes – Department of Physics and the Department of Chemistry, University of Alberta | Scholes Lab, Department of Chemistry, Princeton University, Princeton, NJ, United States | Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy | Vielight Inc
[ Published Study Link | Device: Vielight Neuro Alpha ]
Raman Spectroscopy Reveals Photobiomodulation-Induced α-Helix to β-Sheet Transition in Tubulins: Potential Implications for Alzheimer’s and Other Neurodegenerative Diseases
Institutes – University of Alberta, Polytechnic University of Turin, Freie Universit¨at Berlin, Silesian University of Technology
[ Pre-print | Device: Vielight Neuro Alpha ]
Thanks for visiting our website. We value your time and are always happy to help. Please fill out the contact form below with your name, email address, and message, and we'll get back to you as soon as possible.
We look forward to hearing from you and assisting with any questions or concerns you may have.